DBV Technologies S.A.: DBV Technologies to Participate in Upcoming EAACI Congress 2023

Montrouge, France, June 8, 2023 DBV Technologies to Participate in Upcoming EAACI Congress 2023 DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage

Related Keywords

Zeiten ,Mecklenburg Vorpommern ,Germany ,London ,City Of ,United Kingdom ,Berlin ,Australia ,Montrouge ,France General ,France ,Rome ,Lazio ,Italy ,United States ,Hamburg ,German ,American ,America ,Susanne Lau ,Stefan Klotter ,Sabine Schnadt ,Angela Marcucci ,Daniel Tasse ,Pharis Mohideen ,Katie Matthews ,Stefania Arasi ,Critical Care Medicine Department ,European Academy Of Allergy ,University Of Berlin ,King College London ,Asthma Association ,Company Phase ,Exchange Commission ,Children Research Hospital ,Company Adss ,Stock Market ,European Academy ,Clinical Immunology ,Viaskin Peanut ,Chief Executive Officer ,Patients Living ,Pediatric Allergist ,Paediatric Allergy Unit ,Bambino Ges ,Section Chair ,Deputy Head ,Pediatric Respiratory Medicine ,Medical University ,German Allergy ,College London ,Chief Medical Officer ,Peanut Allergy ,Subjects Aged ,Without Concomitant Asthma ,North America ,North American ,Basking Ridge ,Euronext Paris ,Nasdaq Global Select Market ,Des March ,Stabile Ertr ,Chart Profi Stefan Klotter ,Blue Chips ,Technologies ,Articipate ,Pcoming ,Caaci ,Congress ,023 ,